Lipikar AP+MAX

PROVEN RESULTS

Tested on atopic skin and in oncology patients under dermatological, ophthalmological and pediatric control

6H Visible efficacy​

Visible efficacy​

ELIGIBLE PATIENTS​

Suitable from 0 to 100 years old, even for newborns – all skin tones (Fitzpatrick I-VI)

From newborns ​

Suitable from birth

FAQ

How does it compare to 10% urea?

Superior on all measures at Week 12 in a double-blind RCT (N=60): better SCORAD, TEWL, DLQI, hydration, and skin pH (Prakoeswa, 2025). Confirmed in a second independent RCT (Canchy et al., ISAD, 2024).

Is it safe for newborns?

Yes. Tested under dermatological and paediatric control from the first days of life, with high response rates and good tolerance (Canchy et al., WCPD, 2025).

When do results appear?

TEWL improvement vs urea is measurable from Week 4. Significant differences in SCORAD, DLQI, and hydration emerge between Week 8 and Week 12 (Prakoeswa, 2025).

Does it reduce steroid use?

Yes — 31% less corticosteroid by weight vs standard emollient in a 28-day RCT (N=119; p=0.041) (Zelenkova, 2023).

What about patients with darker skin tones?

Studies across Fitzpatrick I–VI confirm increased NMF levels and improved itch intensity across all skin tones (La Roche-Posay, AAD, 2025).

Clinical Evidence

Before (D0)

After (D28)

Proven results

Tested on skins with atopic background

6H

Visible efficacy

Effect after 6h, dry skin relief for long-lasting hydration

24H

Itch control

For a better quality of life day & night

72H

Moisturizing effect on all skin tones

Long lasting relief for ultra dry to atopic prone skin


*Clinical study, 75 subjects, 72h after stopping the product use once daily for 28 days.
**Consumer study on 139 subjects presenting itch sensations due to dryness. Result 24h after stopping product use following 15 days of product application once a day.



KEY ACTIVE COMPLEX

Neurobioma: Proteasyl + Aqua Posae Filiformis + Microresyl

Neurobioma

NEUROBIOMA TECHNOLOGY

Cutting edge technology inspired from advanced neurosciences research connecting microbiome and neuro-sensorial perception of itch. It helps to reduce itch sensations.

Neurobioma Mode of Action

Novel Itch Pathway Linking S.Aureus Exotoxin to Itch in AD Patients

Access the full publication




Routine

STEP 1 CLEANSE

LIPIKAR SYNDET AP+ 

STEP 1 CLEANSE

LIPIKAR SYNDET AP+ 

Application: Entire body and face, once a day 




Patient Services

FOR KIDS AND PARENTS

Explore the eczema academy, a challenge designed to help kids stay consistent, thereby ensuring the treatment delivers optimal results and reduces relapses.

Get free unlimited access to more articles and resources like this!

L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting edge research, science and education on skin and hair care.